Page last updated: 2024-08-18

xanthenes and Acute Lung Injury

xanthenes has been researched along with Acute Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, W; Pang, Y; Sun, H; Zhao, D1
Chen, N; Chi, G; Deng, Y; Feng, H; Hou, J; Soromou, LW; Wu, Q1

Other Studies

2 other study(ies) available for xanthenes and Acute Lung Injury

ArticleYear
Structured triglyceride attenuates lung injury and inflammation in lipopolysaccharide‑induced acute lung injury by enhancing GPR120 expression.
    Molecular medicine reports, 2021, Volume: 23, Issue:6

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lung; Lung Injury; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; NF-kappa B; RAW 264.7 Cells; Receptors, G-Protein-Coupled; Sulfonamides; Triglycerides; Tumor Necrosis Factor-alpha; Xanthenes

2021
Prime-O-glucosylcimifugin attenuates lipopolysaccharide-induced acute lung injury in mice.
    International immunopharmacology, 2013, Volume: 16, Issue:2

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Monosaccharides; NF-kappa B; Xanthenes

2013